Consolidation growing among health providers but many leaving money on the table
While M&As bustle among providers, the average U.S. health system acquirer is leaving a whopping $30 million annually on the table, according to a new report.
While M&As bustle among providers, the average U.S. health system acquirer is leaving a whopping $30 million annually on the table, according to a new report.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The companies said the new price was due to a decline in the financial status of the medical group, along with a desire to expedite the process of obtaining clearance from the Federal Trade Commission.
Hospital chains that buy up other facilities, clinics and physician offices often tout savings and improved services from coordinating patient care and eliminating inefficiencies. The researchers found no evidence that any potential savings were being passed along to the employers, insurers and patients who pay for the care.
Despite multiple protests and controversy, Southern California-based Prime Healthcare Services appears poised to acquire six hospitals operated by financially strapped Daughters of Charity in California for $300 million. The San Francisco Business Times reports that Daughters CEO Robert Issai said Prime’s offer, which has been protested by California’s biggest healthcare union, SEIU-UHW, would also include […]
Privia Health, which seeks to help physician practices remain independent in lieu of massive consolidation occurring in healthcare, is significantly boosting those efforts with a $400 million national expansion. Backed by an investor group led by an affiliate of Goldman Sachs, the Virginia-based physician practice management group said the expansion is a direct result of the […]
The future of healthcare was all over MedCity CONVERGE 2014, and not just in the form of vague predictions about robot doctors and implanted sensors that track our every biological process. A doctor, an IT expert and a process improvement expert talked about what hospitals will look like in 2024, which ones will still be […]